SVB Leerink raised the price target for the Gilead Sciences Inc. (NASDAQ:GILD) stock to ‘a Mkt perform’. The rating was released on May 23, 2023, according to finviz. We previously noted in another research note published on February 28, 2023 by BMO Capital Markets that downgraded the stock from an Outperform to a Market perform with a price target of $65 for GILD stock. The research report from Wells Fargo has reiterated the stock to Equal Weight, with a price target set at $70. The stock was reiterated by Truist, who disclosed in a research note on February 02, 2023, to Hold and set the price objective to $75.